Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

NCRI 2018 | Improving glioma surgery using a real time fluorescence biomarker

Kathreena Kurian • 8 Nov 2018
NCRI 2018
Brain Tumor Glioma

Correctly distinguishing gliomas as low or high grade during surgery can improve resection and thus survival, as explained here by Kathreena Kurian, MBBS, MD, FRCPath (Neuro), of the University of Bristol, Bristol, UK. The GALA-BIDD study prospectively investigated whether the use of visible fluorescence, through the utilization of 5-ALA, is a good biomarker of high grade disease within a tumour in real time during surgery. We discussed the results of this study, as well as plans for further research, with Dr Kurian at the 2018 National Cancer Research Institute (NCRI) Cancer Conference, held in Glasgow, UK.

More from Kathreena Kurian

Glioma biomarker research
1:35
Glioma biomarker research
Kathreena Kurian • 8 Nov 2018

Related Videos

Practical challenges of adoptive neoantigen-specific T-cell immunotherapy in MGMT-u glioblastoma
0:58
Practical challenges of adoptive neoantigen-specific T-cell immunotherapy in MGMT-u glioblastoma
Tolga Tuncer • 30 May 2026
TVI-AST-008: adoptive neoantigen-specific T-cell immunotherapy in MGMT-u glioblastoma
1:51
TVI-AST-008: adoptive neoantigen-specific T-cell immunotherapy in MGMT-u glioblastoma
Tolga Tuncer • 30 May 2026
Phase II trial of lutetium-177 dotatate in advanced intracranial meningioma
1:32
Phase II trial of lutetium-177 dotatate in advanced intracranial meningioma
Sylvia Kurz • 31 May 2026
Mechanism of 177Lu-dotatate in SSTR2-positive meningioma
1:04
Mechanism of 177Lu-dotatate in SSTR2-positive meningioma
Sylvia Kurz • 30 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals